Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE2 receptor-increasing medication use at hospital admission and ICU mortality in COVID-19
NL-OMON26336Recruiting
- Sponsor
- nonen
- Start
- Mar 2020
- Countries
- 1
01
Overview
Open-label trial in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by nonen. Primary endpoints: mortality and end of mechanical respiratory support. Started Mar 2020; status: recruiting.
02
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NL-OMON26336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON26336.